Table 1.

Baseline characteristics of patients according to medication.

	Group A (n = 17)	Group B (n = 18)	p value
Age, years	68.35 ± 9.99	66.13 ± 7.78	0.493
BMI	24.21 ± 3.28	23.78 ± 3.69	0.729
PV	25.93 ± 6.01	26.36 ± 5.52	0.848
PSA	1.19 ± 1.29	1.41 ± 1.30	0.645
IPSSv	11.24 ± 5.53	9.64 ± 4.67	0.400
IPSSs	8.94 ± 3.19	9.29 ± 3.07	0.763
QoL (IPSS-QoL)	4.79 ± 1.25	4.38 ± 1.60	0.224
IPSS overall	20.18 ± 7.67	18.93 ± 7.10	0.645
OABSS	6.5 ± 2.33	5.0 ± 1.73	0.342
Qmax	10.37 ± 4.47	11.55 ± 9.66	0.685

Values are presented as mean ± standard deviation. Group A: tamsulosin + mirabegron; group B: tamsulosin + solifenacin.

BMI, body mass index; IPSS, International Prostate Symptom Score; IPSSs, storage symptom score; IPSSv, voiding symptom score; OABSS, Overactive Bladder Symptom Score; PSA, prostate-specific antigen; PV, measured prostate volume; Qmax, peak flow rate, QoL, quality of life.